ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.41M	-
Other	Edwards Larry Todd	150.2K	$3.94M	-
Other	Matsuda Masaru	127.6K	$3.34M	-
Other	Burnett Patrick	120.2K	$3.15M	-
CFO	Vairavan Latha	86.0K	$2.25M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 17, 2026	Welgus Howard G.61	Director	Sale+OE	4,731	$24.58	$116,280.94	-5.9%	-	-
Jun 15, 2026	Lin Sue-Jean	Director	Sell	4,946	$24.38	$120,586.94	-15.2%	-	-
May 11, 2026	Burnett Patrick	See Remarks	Sell	222	$21.05	$4,673.10	-0.2%	-	-
May 11, 2026	Vairavan Latha	SVP Chief Financial Officer	Sell	435	$21.05	$9,156.75	-0.5%	-	-
May 4, 2026	Matsuda Masaru51	See Remarks	Sell	8,256	$23.31	$192,415.26	-3.1%	-	-
Feb 2, 2026	Matsuda Masaru51	See Remarks	Sell	40,638	$25.28	$1,027,292.65	-7.5%	-8.7%	-
Jan 5, 2026	Burnett Patrick	See Remarks	Sell	2,490	$28.98	$72,165.68	-2.6%	-21.7%	-
Jan 2, 2026	Welgus Howard G.61	Director	Sell	10,000	$28.96	$289,606.00	-12.5%	-18.5%	-
Dec 31, 2025	Burnett Patrick	See Remarks	Sell	1,697	$29.20	$49,560.24	-0.9%	-18.9%	-
Dec 15, 2025	Burnett Patrick	See Remarks	Sale+OE	11,500	$28.94	$332,851.40	-10.5%	-21.4%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC